Revenue mapping, production volume analysis, and application-specific demand modeling were employed to determine the global market valuation. The methodology comprised the following:
• Identification of over 50 main manufacturers and microalgae cultivators in North America (Cyanotech, Kemin), Europe (Algatechnologies, AstaReal), Asia-Pacific (Fuji Chemical, Zhejiang Medicine, BGG), and Latin America
• Product mapping between natural astaxanthin (Haematococcus pluvialis microalgae, Phaffia yeast fermentation) and synthetic astaxanthin (petrochemical-derived), as well as between dried forms (beadlets, powders, granules) and liquid forms (oleoresin, emulsions, softgels).
• Segmentation based on application, including Food & Beverages (functional foods, fortified beverages), Pharmaceuticals & Nutraceuticals (dietary supplements, softgels, tablets), Animal Feed (salmon aquaculture, poultry, shrimp farming), and Personal Care (uv-protection serums, anti-aging lotions)
• Examination of the annual revenues reported and modeled for astaxanthin portfolios, which includes the upstream microalgae cultivation capacity (measured in hectares of photobioreactors and tubular systems) and downstream extraction yields
• Primary producers and contract cultivation operations are included in the coverage of manufacturers that will account for 75-80% of the global market share in 2024.
• Segment-specific valuations for natural vs. synthetic sub-markets and regional demand matrices are derived through extrapolation using bottom-up (cultivation capacity × extraction efficiency × price per kg by concentration grade by country) and top-down (manufacturer revenue validation, aquaculture feed additive spend analysis) approaches.